Influence of other maternal variables on the relationship between maternal virus load and mother-to-infant transmission of human immunodeficiency virus type 1

Journal of Infectious Diseases

Volumn 175, Issue 5, 1997, Pages 1206-1210

  Burns, David N ^a   Landesman, Sheldon ^b   Wright, David J ^b   Waters, David ^b   Mitchell, Richard M ^b   Rubinstein, Arye ^b   Willoughby, Anne ^b   Goedert, James J ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; DEMOGRAPHY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MATERNAL BLOOD; MATERNAL DISEASE; NEWBORN INFECTION; PRIORITY JOURNAL; RISK FACTOR; RNA ANALYSIS; VIRUS TRANSMISSION;

EID: 0030898198     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/593569     Document Type: Article

References (15)

1. St Louis ME, Kamenga M, Brown C, et al. Risk for perinatal HIV-1 transmission according to maternal immunologie, virologie, and placental factors. JAMA 1993;269:2853-9.
2. Rodriguez EM, Mofenson LM, Chang BH, et al. Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission. AIDS 1996;10:273-82.
3. Landesman S, Kalish LA, Burns DN, et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. N Engl J Med 1996;334:1617-23.
4. Matheson PB, Thomas PA, Abrams EJ, et al. Heterosexual behavior during pregnancy and perinatal transmission of HIV-1. AIDS 1996;10:1249-56.
5. Lin HJ, Myers LE, Yen-Lieberman B, et al. Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis 1994;170:553-62.
6. Mellors JW, Kingsley LA, Rinaldo CR, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-9.
7. Fang G, Burger H, Grimson R, et al. Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission. Proc Natl Acad Sci USA 1995;92:12100-4.
8. Dickover RE, Garratty EM, Herman SA, et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission: effect of maternal zidovudine treatment on viral load. JAMA 1996;275:599-605.
9. Burchett SK, Kornegay J, Pitt J, et al. Assessment of maternal plasma HIV viral load as a correlate of vertical transmission [abstract LB3]. In: Program and abstracts: 3rd Conference on Retroviruses and Opportunistic Infections (Washington, DC). Alexandria, VA: Infectious Diseases Society of America, 1996:161.
10. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 1996;335:1621-9.
11. + levels. J Acquir Immune Defic Syndr 1994;7:718-26.
12. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noorda J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990;28:495-503.
13. Ercoli L, Sarmati L, El-Sawaf G, et al. Plasma viremia titration and RNA quantitation in ICD-p24 negative HIV type-1 -infected patients. AIDS Res Hum Retroviruses 1995;11:1203-7.
14. Kim JH, McLinden RJ, Mosca JD, et al. Transcriptional effects of superinfection in HIV chronically infected T cells: studies in dually infected clones. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:329-42.
15. Holodniy M, Mole L, Yen-Lieberman B, et al. Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in VACUTAINER CPT, VACUTAINER PPT, and standard VACUTAINER tubes. J Clin Microbiol 1995;33:1562-6.